GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Supriya Lifescience Ltd (BOM:543434) » Definitions » EV-to-EBITDA

Supriya Lifescience (BOM:543434) EV-to-EBITDA : 16.98 (As of Jun. 23, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Supriya Lifescience EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Supriya Lifescience's enterprise value is ₹31,228 Mil. Supriya Lifescience's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ₹1,839 Mil. Therefore, Supriya Lifescience's EV-to-EBITDA for today is 16.98.

The historical rank and industry rank for Supriya Lifescience's EV-to-EBITDA or its related term are showing as below:

BOM:543434' s EV-to-EBITDA Range Over the Past 10 Years
Min: 8.79   Med: 13.21   Max: 18.06
Current: 16.98

During the past 6 years, the highest EV-to-EBITDA of Supriya Lifescience was 18.06. The lowest was 8.79. And the median was 13.21.

BOM:543434's EV-to-EBITDA is ranked worse than
65.58% of 462 companies
in the Biotechnology industry
Industry Median: 8.545 vs BOM:543434: 16.98

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-23), Supriya Lifescience's stock price is ₹397.20. Supriya Lifescience's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹14.800. Therefore, Supriya Lifescience's PE Ratio for today is 26.84.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Supriya Lifescience EV-to-EBITDA Historical Data

The historical data trend for Supriya Lifescience's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Supriya Lifescience EV-to-EBITDA Chart

Supriya Lifescience Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-EBITDA
Get a 7-Day Free Trial - - 17.12 10.14 14.14

Supriya Lifescience Quarterly Data
Mar19 Mar20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.14 13.11 13.81 13.82 14.14

Competitive Comparison of Supriya Lifescience's EV-to-EBITDA

For the Biotechnology subindustry, Supriya Lifescience's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Supriya Lifescience's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Supriya Lifescience's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Supriya Lifescience's EV-to-EBITDA falls into.



Supriya Lifescience EV-to-EBITDA Calculation

Supriya Lifescience's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=31227.998/1838.71
=16.98

Supriya Lifescience's current Enterprise Value is ₹31,228 Mil.
Supriya Lifescience's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,839 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Supriya Lifescience  (BOM:543434) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Supriya Lifescience's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=397.20/14.800
=26.84

Supriya Lifescience's share price for today is ₹397.20.
Supriya Lifescience's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹14.800.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Supriya Lifescience EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Supriya Lifescience's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Supriya Lifescience (BOM:543434) Business Description

Traded in Other Exchanges
Address
Sonawala Road, 207/208, Udyog Bhavan, Goregaon East, Mumbai, MH, IND, 400063
Supriya Lifescience Ltd is a manufacturer of Active pharmaceutical Ingredients. It is focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and anti-allergic.

Supriya Lifescience (BOM:543434) Headlines

No Headlines